MOA-728

· Bausch Health Americas, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for MOA-728, covering 2010-05-11 to 2020-08-20. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant Pain [Phase 2]